Univariable analysis revealed a significantly higher risk of death for metastatic PCa patients with high age at sequencing, more metastatic count and metastatic site count, TP53 truncating mutations, TP53 other mutations, RB1 deletion or mutation, BRCA1 mutation or deletion, AR amplification and PTEN deletion. Here, AR is linked to posterior cortical atrophy.